Gemcitabine enhances cytotoxic activity of effector T-lymphocytes against chemo-resistant cholangiocarcinoma cells

Gemcitabine enhances cytotoxic activity of effector T-lymphocytes against chemo-resistant cholangiocarcinoma cells

© 2019 Elsevier B.V. Cholangiocarcinoma (CCA) can resist chemotherapy resulting in treatment failure. Gemcitabine, a chemotherapeutic drug, can sensitize cancer cells to become susceptible to cytotoxic T-lymphocytes (CTLs). We, therefore, hypothesized that a combination of gemcitabine and CTLs would...

Full description

Saved in:
Bibliographic Details
Main Authors: Nunghathai Sawasdee, Chutamas Thepmalee, Jatuporn Sujjitjoon, Petlada Yongpitakwattana, Mutita Junking, Naravat Poungvarin, Pa thai Yenchitsomanus, Aussara Panya
Format: Journal
Published: 2020
Subjects:
Immunology and Microbiology
Medicine
Pharmacology, Toxicology and Pharmaceutics
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85076520956&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/68436
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University

Internet

https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85076520956&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/68436

Similar Items